{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T21:06:46Z","timestamp":1768079206965,"version":"3.49.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Key R&D Program","award":["2017YFC0909302"],"award-info":[{"award-number":["2017YFC0909302"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81373489"],"award-info":[{"award-number":["81373489"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81422052"],"award-info":[{"award-number":["81422052"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81673518"],"award-info":[{"award-number":["81673518"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002822","name":"Central South University","doi-asserted-by":"publisher","award":["2018zzts902"],"award-info":[{"award-number":["2018zzts902"]}],"id":[{"id":"10.13039\/501100002822","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gene"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.gene.2018.08.027","type":"journal-article","created":{"date-parts":[[2018,8,7]],"date-time":"2018-08-07T13:09:59Z","timestamp":1533647399000},"page":"226-232","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["CRISPLD1 rs12115090 polymorphisms alters antiplatelet potency of clopidogrel in coronary artery disease patients in Chinese Han"],"prefix":"10.1016","volume":"678","author":[{"given":"Jie-Ya","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan-Jiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"He","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Lei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mu-Peng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei-Yuan","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi-Lin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Ming","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Ping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gene.2018.08.027_bb0005","doi-asserted-by":"crossref","first-page":"8062796","DOI":"10.1155\/2017\/8062796","article-title":"The personalization of clopidogrel antiplatelet therapy: the role of integrative pharmacogenetics and pharmacometabolomics","volume":"2017","author":"Amin","year":"2017","journal-title":"Cardiol. Res. Pract."},{"key":"10.1016\/j.gene.2018.08.027_bb0010","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ejps.2018.03.011","article-title":"Pharmacometabolomics analysis of plasma to phenotype clopidogrel high on treatment platelets reactivity in coronary artery disease patients","volume":"117","author":"Amin","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.gene.2018.08.027_bb0015","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/j.jacc.2006.11.044","article-title":"Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectives","volume":"49","author":"Angiolillo","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.gene.2018.08.027_bb0020","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.jacc.2010.04.047","article-title":"Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate","volume":"56","author":"Bonello","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.gene.2018.08.027_bb0025","first-page":"9266","article-title":"Both PON1 Q192R and CYP2C19*2 influence platelet response to clopidogrel and ischemic events in Chinese patients undergoing percutaneous coronary intervention","volume":"8","author":"Chen","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.gene.2018.08.027_bb0030","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/bdra.20737","article-title":"Nonsyndromic cleft lip and palate: CRISPLD genes and the folate gene pathway connection","volume":"91","author":"Chiquet","year":"2011","journal-title":"Birth Defects Res. A Clin. Mol. Teratol."},{"key":"10.1016\/j.gene.2018.08.027_bb0035","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.jacc.2012.11.040","volume":"61","author":"Frelinger","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.gene.2018.08.027_bb0040","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1210\/er.2008-0032","article-title":"The CAP superfamily: cysteine-rich secretory proteins, antigen 5, and pathogenesis-related 1 proteins\u2013roles in reproduction, cancer, and immune defense","volume":"29","author":"Gibbs","year":"2008","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.gene.2018.08.027_bb0045","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.thromres.2006.08.012","article-title":"Clopidogrel resistance?","volume":"120","author":"Gurbel","year":"2007","journal-title":"Thromb. Res."},{"key":"10.1016\/j.gene.2018.08.027_bb0050","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1084\/jem.20150806","article-title":"Functional screen identifies regulators of murine hematopoietic stem cell repopulation","volume":"213","author":"Holmfeldt","year":"2016","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.gene.2018.08.027_bb0055","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1182\/blood-2006-04-013052","article-title":"Cytochrome P450 2C19 loss-of-function polymorphism is a major determinant of clopidogrel responsiveness in healthy subjects","volume":"108","author":"Hulot","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.gene.2018.08.027_bb0060","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.amjcard.2012.04.020","article-title":"Meta-analysis of cytochrome P450 2C19 polymorphism and risk of adverse clinical outcomes among coronary artery disease patients of different ethnic groups treated with clopidogrel","volume":"110","author":"Jang","year":"2012","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.gene.2018.08.027_bb0065","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.jstrokecerebrovasdis.2014.09.014","article-title":"CYP2C19 genotype and early ischemic lesion recurrence in stroke patients treated with clopidogrel","volume":"24","author":"Jeong","year":"2015","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"10.1016\/j.gene.2018.08.027_bb0070","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1517\/14656566.2012.666524","article-title":"Genetic and non-genetic factors affecting the response to clopidogrel therapy","volume":"13","author":"Karazniewicz-Lada","year":"2012","journal-title":"Expert. Opin. Pharmacother."},{"key":"10.1016\/j.gene.2018.08.027_bb0075","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1124\/dmd.109.029132","article-title":"Identification of the human cytochrome P450 enzymes involved in the two oxidative steps in the bioactivation of clopidogrel to its pharmacologically active metabolite","volume":"38","author":"Kazui","year":"2010","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.gene.2018.08.027_bb0080","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1056\/NEJMe038191","article-title":"Antiplatelet therapy for ischemic heart disease","volume":"350","author":"Lange","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.gene.2018.08.027_bb0085","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jtcvs.2016.07.044","article-title":"2016 ACC\/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"152","author":"Levine","year":"2016","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.gene.2018.08.027_bb0090","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.1016\/j.jacc.2012.11.019","article-title":"2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"61","author":"O'Gara","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.gene.2018.08.027_bb0095","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1161\/CIRCULATIONAHA.116.024531","article-title":"Impact of optimal medical therapy in the dual antiplatelet therapy study","volume":"134","author":"Resor","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.gene.2018.08.027_bb0100","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1161\/CIR.0b013e3182456d46","article-title":"Executive summary: heart disease and stroke statistics\u20132012 update: a report from the American Heart Association","volume":"125","author":"Roger","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.gene.2018.08.027_bb0105","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/clpt.2011.132","article-title":"Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450-2C19 (CYP2C19) genotype and clopidogrel therapy","volume":"90","author":"Scott","year":"2011","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.gene.2018.08.027_bb0110","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/cpt.401","article-title":"Exome sequencing of extreme clopidogrel response phenotypes identifies B4GALT2 as a determinant of on-treatment platelet reactivity","volume":"100","author":"Scott","year":"2016","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.gene.2018.08.027_bb0115","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1001\/jama.2009.1232","article-title":"Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy","volume":"302","author":"Shuldiner","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.gene.2018.08.027_bb0120","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1161\/CIRCULATIONAHA.109.885194","article-title":"Cytochrome 2C19*17 allelic variant, platelet aggregation, bleeding events, and stent thrombosis in clopidogrel-treated patients with coronary stent placement","volume":"121","author":"Sibbing","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.gene.2018.08.027_bb0125","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1056\/NEJMoa0808227","article-title":"Genetic determinants of response to clopidogrel and cardiovascular events","volume":"360","author":"Simon","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.gene.2018.08.027_bb0130","doi-asserted-by":"crossref","first-page":"350","DOI":"10.4103\/0253-7613.186191","article-title":"Evaluation of CYP2C19, P2Y12, and ABCB1 polymorphisms and phenotypic response to clopidogrel in healthy Indian adults","volume":"48","author":"Sridharan","year":"2016","journal-title":"Indian J. Pharm."},{"key":"10.1016\/j.gene.2018.08.027_bb0135","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S0140-6736(13)61170-8","article-title":"Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study","volume":"382","author":"Stone","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.gene.2018.08.027_bb0140","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3389\/fphar.2016.00453","article-title":"Impact of CYP2C19 variants on clinical efficacy of clopidogrel and 1-year clinical outcomes in coronary heart patients undergoing percutaneous coronary intervention","volume":"7","author":"Sun","year":"2016","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.gene.2018.08.027_bb0145","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1016\/j.jacc.2013.07.101","article-title":"Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding","volume":"62","author":"Tantry","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.gene.2018.08.027_bb0150","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/j.jacc.2007.12.056","article-title":"Cytochrome P450 2C19 681G>A polymorphism and high on-clopidogrel platelet reactivity associated with adverse 1-year clinical outcome of elective percutaneous coronary intervention with drug-eluting or bare-metal stents","volume":"51","author":"Trenk","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.gene.2018.08.027_bb0155","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/cpdd.259","article-title":"The pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel in healthy Japanese volunteers","volume":"5","author":"Umemura","year":"2016","journal-title":"Clin. Pharmacol. Drug Dev."},{"key":"10.1016\/j.gene.2018.08.027_bb0160","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00228-008-0574-7","article-title":"The CYP2C19 ultra-rapid metabolizer genotype influences the pharmacokinetics of voriconazole in healthy male volunteers","volume":"65","author":"Wang","year":"2009","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.gene.2018.08.027_bb0165","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.gene.2014.12.051","article-title":"Genetic polymorphisms of CYP2C19 2 and ABCB1 C3435T affect the pharmacokinetic and pharmacodynamic responses to clopidogrel in 401 patients with acute coronary syndrome","volume":"558","author":"Wang","year":"2015","journal-title":"Gene"},{"key":"10.1016\/j.gene.2018.08.027_bb0170","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4103\/1735-1995.193502","article-title":"Relationship between clopidogrel-related polymorphisms and variable platelet reactivity at 1\u202fyear: a cohort study from Han Chinese","volume":"21","author":"Wang","year":"2016","journal-title":"J. Res. Med. Sci."},{"key":"10.1016\/j.gene.2018.08.027_bb0175","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.5551\/jat.33290","article-title":"Association of cytochrome P450 genetic variants with clopidogrel resistance and outcomes in acute ischemic stroke","volume":"23","author":"Yi","year":"2016","journal-title":"J. Atheroscler. Thromb."},{"key":"10.1016\/j.gene.2018.08.027_bb0180","first-page":"725","article-title":"Dual versus single antiplatelet therapy for patients with long-term oral anticoagulation undergoing coronary intervention: a systematic review and meta-analysis","volume":"14","author":"Yu","year":"2017","journal-title":"J. Geriatr. Cardiol."},{"key":"10.1016\/j.gene.2018.08.027_bb0185","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/1440-1681.12325","article-title":"Non-antiplatelet effect of clopidogrel: improving endothelial function in Chinese healthy subjects with different CYP2C19 genotype","volume":"42","author":"Zhang","year":"2015","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.gene.2018.08.027_bb0190","article-title":"Pharmacokinetic and pharmacodynamic responses to clopidogrel: evidences and perspectives","volume":"14","author":"Zhang","year":"2017","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.gene.2018.08.027_bb0195","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1124\/jpet.112.201640","article-title":"Carboxylesterase 1 as a determinant of clopidogrel metabolism and activation","volume":"344","author":"Zhu","year":"2013","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["Gene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111918308898?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111918308898?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,4]],"date-time":"2018-10-04T10:22:40Z","timestamp":1538648560000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378111918308898"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":39,"alternative-id":["S0378111918308898"],"URL":"https:\/\/doi.org\/10.1016\/j.gene.2018.08.027","relation":{},"ISSN":["0378-1119"],"issn-type":[{"value":"0378-1119","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CRISPLD1 rs12115090 polymorphisms alters antiplatelet potency of clopidogrel in coronary artery disease patients in Chinese Han","name":"articletitle","label":"Article Title"},{"value":"Gene","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gene.2018.08.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}